Skip to main
  1. Stocks
  2. AMN Healthcare Services
  3. Forecast
AMN

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

AMN Healthcare Services is viewed favorably because its core Nurse and Allied business is stabilizing, with a return to volume growth for the first time since 2022, bill rates improving 6% year over year, and average hours rising sequentially, while labor disruption revenue of $722M in Q1 far exceeded expectations. The company also delivered strong operating execution, with Q1 revenue and EBITDA beating consensus by 12% and 35%, gross margin expanding to 25.1% in Nurse and Allied and consolidated adjusted EBITDA margin reaching 12.1%, suggesting meaningful operating leverage as demand normalizes. Its balance sheet remains manageable with net leverage at 1.6x and a target of 2.0x or less across the balance of 2026, while international nursing recovery and tuck-in acquisitions in Q2 add further support to a path toward double-digit EBITDA growth.

Bears say

AMN Healthcare Services is facing weakening fundamentals across its core staffing businesses, with Physician and Leadership revenue down 6% to $164M as locum tenens revenue fell 7% Y/Y, days declined 9%, and segment gross margin compressed 120 bps Y/Y to 26.1%. Technology and Workforce revenue dropped 15% Y/Y to $87M, and despite a 50% gross margin, continued softness in language services and VMS software plus management’s Q2 outlook for revenue flat to down 2% Y/Y point to sustained demand deterioration. The broader thesis is further pressured by organic revenue turning from +9% in 2024 to -4% in 2025, an expected another -4% in 2026, and nearly $1B of debt against declining revenue, while VMS revenue has fallen at a (35%) CAGR from 2022 to 2025 amid secular pressure on contract labor.

AMN has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

AMN Analyst Forecast & Price Prediction

Get the latest AMN stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in AMN

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Buy based on their latest research and market trends.

According to 5 analysts, AMN has a Buy consensus rating as of Oct 31, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $36.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $36.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


AMN Analyst Forecast & Price Prediction

Get the latest AMN stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in AMN

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover AMN stock data and trends